Aquagenic Pruritus

Search Trials
Aquagenic Pruritus in Myeloproliferative Neoplasms
Status:
Unknown status
Last Changed:
Aug 9, 2019
First Changed:
Jul 12, 2019
Disease(s):
Deciphering Aquagenic Pruritus in Myeloproliferaitive Neoplasms
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Dec 21, 2021
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Aprepitant Versus Hydroxyzine in Persistent Aquagenic Pruritus for Patients With Myeloproliferative Neoplasms
Status:
Recruiting
Last Changed:
Jun 11, 2021
First Changed:
Jan 18, 2019
Disease(s):
Myeloproliferative Disorder
Intervention(s):
Aprepitant 80 mgHydroxyzine 25mgPlacebo of HydroxyzinePlacebo of Aprepitant
Clinical Characteristics of Aquagenic Pruritus in Patients With Myeloproliferative Neoplasms
Status:
Completed
Last Changed:
Jul 1, 2019
First Changed:
Sep 28, 2018
Disease(s):
Myeloproliferative Disorder

Connect. Empower. Inspire.